Chemomab Therapeutics Ltd. Shortterm Employee Benefits Expense
Chemomab Therapeutics Ltd. (CMMB) reported Shortterm Employee Benefits Expense of $1.38 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ShorttermEmployeeBenefitsExpense · last filed 2019-04-24
| Period end | Shortterm Employee Benefits Expense 12 month |
|---|---|
| 2018-12-31 | $1.38M 20-F · filed 2019-04-24 |
| 2017-12-31 | $1.08M 20-F · filed 2019-04-24 |
| 2016-12-31 | $794.00K 20-F · filed 2019-04-24 |